160 related articles for article (PubMed ID: 25401297)
61. In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants.
Soverini S; De Benedittis C; Castagnetti F; Gugliotta G; Mancini M; Bavaro L; Machova Polakova K; Linhartova J; Iurlo A; Russo D; Pane F; Saglio G; Rosti G; Cavo M; Baccarani M; Martinelli G
BMC Cancer; 2016 Aug; 16():572. PubMed ID: 27485109
[TBL] [Abstract][Full Text] [Related]
62. Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects.
Berger R; Chen SJ; Chen Z
Cancer Genet Cytogenet; 1990 Feb; 44(2):143-52. PubMed ID: 2404570
[No Abstract] [Full Text] [Related]
63. Coexistence of BCR/ABL1 p190 transcript and CEBPA double mutations in de novo acute myeloid leukemia.
Zhang X; Guo X
Leuk Lymphoma; 2019 Nov; 60(11):2844-2846. PubMed ID: 31050567
[No Abstract] [Full Text] [Related]
64. Molecular Response of e19a2 BCR-ABL1 Chronic Myeloid Leukemia With Double Philadelphia Chromosome to Dasatinib.
Ikeda K; Harada-Shirado K; Matsumoto H; Noji H; Ogawa K; Takeishi Y
J Clin Oncol; 2016 May; 34(14):e130-3. PubMed ID: 24752059
[No Abstract] [Full Text] [Related]
65. Clonal evolution with acquisition of
Thakral B; Daver N; Tang Z; Patel KP; Ok CY; Loghavi S; Khoury JD; Alotaibi AS; Konopleva M; Yilmaz M; Medeiros LJ
Leuk Lymphoma; 2020 Dec; 61(13):3243-3246. PubMed ID: 32696696
[No Abstract] [Full Text] [Related]
66. [Nilotinib as a second-line treatment for chronic myeloid leukemia].
Yamauchi T; Ueda T
Gan To Kagaku Ryoho; 2011 Jun; 38(6):911-5. PubMed ID: 21677481
[TBL] [Abstract][Full Text] [Related]
67. Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcome.
Reboursiere E; Chantepie S; Gac AC; Reman O
Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):28-33. PubMed ID: 25300567
[TBL] [Abstract][Full Text] [Related]
68. Deep molecular responses achieved in chronic myeloid leukemia in chronic phase patients with BCR-ABL1 >10% at 3 months who are early switched to nilotinib.
Yue Y; Gui X; He X; Chen Y; Pan J; Qiu H; Wu D; Chen S; Guo L; Cen J
Hematology; 2016 May; 21(4):213-7. PubMed ID: 26183593
[TBL] [Abstract][Full Text] [Related]
69. Detection and Clinical Implications of a Novel
Stella S; Massimino M; Tirrò E; Vitale SR; Accurso V; Puma A; Pennisi MS; DI Gregorio S; Romano C; DI Raimondo F; Siragusa S; Manzella L
Anticancer Res; 2019 Dec; 39(12):6965-6971. PubMed ID: 31810968
[TBL] [Abstract][Full Text] [Related]
70. Molecular and Clinical Insights in the Increasing Detection of
DE Pinho Pessoa FMC; Nogueira BMD; Machado CB; Barreto IV; DA Costa Machado AK; Gadelha RB; DE Sousa Oliveira D; Ribeiro RM; Silva FAC; Gurgel LA; Medeiros JC; DA Rocha Maciel A; Lopes GS; Vieira RPG; DE Moraes Filho MO; DE Moraes MEA; Khayat AS; Moreira-Nunes CA
In Vivo; 2024; 38(4):2016-2023. PubMed ID: 38936913
[TBL] [Abstract][Full Text] [Related]
71. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
[TBL] [Abstract][Full Text] [Related]
72. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
Quintás-Cardama A; Kantarjian H; Abruzzo LV; Cortes J
Leukemia; 2007 Nov; 21(11):2394-6. PubMed ID: 17690707
[No Abstract] [Full Text] [Related]
73. Near-hexaploid Ph-positive acute myeloid leukemia with major-BCR/ABL transcript.
Iwama H; Ohyashiki K; Ohyashiki JH; Shimamoto T; Fujimura T; Kawakubo K; Kuriyama Y; Kodama A; Toyama K
Cancer Genet Cytogenet; 1996 Jan; 86(1):61-4. PubMed ID: 8616789
[TBL] [Abstract][Full Text] [Related]
74. Sustained Complete Remission with Incomplete Hematologic Recovery (CRi) in a Patient with Relapsed AML and Concurrent BCR-ABL1 and CBFB Rearrangement Treated with a Combination of Venetoclax and 5-Azacytidine.
Levato L; Gianfelici V; Caglioti F; Russo A; Giugliano E; Mannella A; Molica S
Chemotherapy; 2020; 65(1-2):51-53. PubMed ID: 32570264
[TBL] [Abstract][Full Text] [Related]
75. Insertion of the 5' part of BCR within the ABL gene at 9q34 in a Philadelphia-negative chronic myeloid leukemia.
Vieira L; Alves AC; Marques B; Reis I; Jorge G; Ambrósio AP; de Sousa AB; Boavida MG
Cancer Genet Cytogenet; 1999 Oct; 114(1):17-21. PubMed ID: 10526530
[TBL] [Abstract][Full Text] [Related]
76. Abrupt evolution of Philadelphia chromosome-positive acute myeloid leukemia in myelodysplastic syndrome.
Fukunaga A; Sakoda H; Iwamoto Y; Inano S; Sueki Y; Yanagida S; Arima N
Eur J Haematol; 2013 Mar; 90(3):245-9. PubMed ID: 23240925
[TBL] [Abstract][Full Text] [Related]
77. Use of mate-pair sequencing to characterize a complex cryptic BCR/ABL1 rearrangement observed in a newly diagnosed case of chronic myeloid leukemia.
Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Kearney HM; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP
Hum Pathol; 2019 Jul; 89():109-114. PubMed ID: 30267776
[TBL] [Abstract][Full Text] [Related]
78. Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paper.
Soverini S; Albano F; Bassan R; Fabbiano F; Ferrara F; Foà R; Olivieri A; Rambaldi A; Rossi G; Sica S; Specchia G; Venditti A; Barosi G; Pane F
Cancer Med; 2020 May; 9(9):2960-2970. PubMed ID: 32154668
[TBL] [Abstract][Full Text] [Related]
79. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
[TBL] [Abstract][Full Text] [Related]
80. BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.
Zagaria A; Anelli L; Coccaro N; Tota G; Casieri P; Cellamare A; Impera L; Brunetti C; Minervini A; Minervini CF; Delia M; Cumbo C; Orsini P; Specchia G; Albano F
Virchows Arch; 2015 Sep; 467(3):357-63. PubMed ID: 26149409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
